While vedolizumab's effect on fistula closure rate in the maintenance phase of vedolizumab responders did not reach statistical significance in Group 2a, but with a minimal statistically significant impact on fistula closure rate in Group 2b compared to placebo.
← all excerpts
Comparison of the Efficacy of the Various Treatment Modalities in the Management of Perianal Crohn's Fistula: A Review.
1
—
—